Skip to main content

Advertisement

SpringerLink
Log in

Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Zupancic M, Shah PC, Shah-Khan F (2007) Gemcitabine-associated thrombotic thrombocytopenic purpura. Lancet Oncol 8:634–641

    Article  PubMed  CAS  Google Scholar 

  2. Lewin SN, Mutch DG, Withcomb BP et al (2005) Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin. Gynecol Oncol 97:228–233

    Article  PubMed  Google Scholar 

  3. Citarrella P, Gebbia V, Teresi M et al (2002) Hemolytic uremic syndrome after chemotherapy with gemcitabine and taxotere: a case report. Anticancer Res 22:1183–1185

    PubMed  Google Scholar 

  4. Alberts SR, Townley PM, Goldberg RM et al (2003) Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study. Ann Oncol 14:580–585

    Article  PubMed  CAS  Google Scholar 

  5. Muller S, Schutt P, Bojko P et al (2005) Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Ann Hematol 84:110–114

    Article  PubMed  CAS  Google Scholar 

  6. Furlan M, Robles R, Galbusera M et al (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome. N Engl J Med 339:1578–1584

    Article  PubMed  CAS  Google Scholar 

  7. George JN (2006) Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354:1927–1935

    Article  PubMed  CAS  Google Scholar 

  8. Vessely SK, George JN, Lammle B et al (2003) ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 102:60–68

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Hematology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium

    D. De Smet & K. Jochmans

  2. Department of Medical Oncology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090, Brussels, Belgium

    B. Neyns

Authors
  1. D. De Smet
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. K. Jochmans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. B. Neyns
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. De Smet.

Rights and permissions

Reprints and permissions

About this article

Cite this article

De Smet, D., Jochmans, K. & Neyns, B. Development of thrombotic thrombocytopenic purpura after a single dose of gemcitabine. Ann Hematol 87, 495–496 (2008). https://doi.org/10.1007/s00277-007-0429-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-007-0429-9

Keywords

Search

Navigation